All In MedTech

Device Trial Radar · NCT01864291

Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects

Study of the Nucleus 24 and ABI541 Auditory Brainstem Implants in Pediatric Non-Neurofibromatosis Type 2

Last checked: Nov 20, 2026Latest source record: Jun 2, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

9

Actual

Start

May 2013

Primary completion

Apr 25, 2019

Study completion Apr 25, 2019

Sponsor

Lead sponsor
Massachusetts Eye and Ear InfirmaryAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 29, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 months, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to determine whether Auditory Brainstem Implant (ABI) can improve hearing in children who are deaf and cannot receive a cochlear implants.

Conditions

  • Bilateral Hearing Loss for Causes Other Than Tumors

Interventions

  • Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI)Device

    Nucleus ABI541 Auditory Brainstem Implant (ABI) surgery followed by device activation, testing, and clinical assessment for five years following surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Major or Minor ABI ComplicationsTime frame: 1 year from date of surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Massachusetts Eye and Ear Infirmary

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.